FUSED HETEROCYCLIC COMPOUND
    5.
    发明公开
    FUSED HETEROCYCLIC COMPOUND 审中-公开
    熔合杂环化合物

    公开(公告)号:EP3275874A1

    公开(公告)日:2018-01-31

    申请号:EP16772669.4

    申请日:2016-03-25

    摘要: The present invention relates to a condensed heterocyclic compound that has an enteropeptidase inhibitory effect, and use of the compound as a medicament for the treatment or prevention of obesity, diabetes mellitus, or the like. Specifically, the present invention relates to a compound represented by the formula (I) or a salt thereof, and use of the compound as a medicament for the treatment or prevention of obesity, diabetes mellitus, or the like [in the formula, each symbol is as defined in the specification].

    摘要翻译: 本发明涉及具有肠肽酶抑制作用的缩合杂环化合物,以及该化合物作为用于治疗或预防肥胖,糖尿病等的药物的用途。 具体而言,本发明涉及由式(I)表示的化合物或其盐,以及该化合物作为用于治疗或预防肥胖,糖尿病等的药物的用途[在式中,每个符号 如说明书中所定义]。

    HETEROCYCLIC COMPOUND
    6.
    发明公开
    HETEROCYCLIC COMPOUND 审中-公开
    杂环化合物

    公开(公告)号:EP3105228A1

    公开(公告)日:2016-12-21

    申请号:EP15706547.5

    申请日:2015-02-12

    CPC分类号: C07D261/04 C07D413/10

    摘要: A fused heterocyclic compound having an enteropeptidase inhibitory action and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided. Specifically, a compound represented by the following formula (I): wherein each symbol is as defined herein, or a salt thereof and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided.

    摘要翻译: 提供了具有肠肽酶抑制作用的稠合杂环化合物以及该化合物作为用于治疗或预防肥胖,糖尿病等的药物的用途。 具体而言,提供了由下式(I)表示的化合物:其中各符号如本文所定义,或其盐,以及该化合物作为用于治疗或预防肥胖,糖尿病等的药物的用途。